ASLAN Pharmaceuticals Limited (ASLN) Misses Q1 EPS by 109c
Tweet
Share
E-mailGet Alerts ASLN Hot Sheet
Join SI Premium – FREE
ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) reported Q1 EPS of ($1.29), $1.09 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on ASLAN Pharmaceuticals Limited (ASLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Pulmatrix (PULM) Reports Q2 Loss of $0.29
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
